Atezolizumab as 1L therapy for advanced NSCLC in PD-L1 selected patients: Updated ORR, PFS and OS data from the BIRCH study Meeting Abstract
| Authors: | Garassino, M.; Rizvi, N.; Besse, B.; Jänne, P.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; Felip, E.; Chaft, J.; Qiu, J.; Kowanetz, M.; Coleman, S.; Mocci, S.; Sandler, A.; Gettinger, S.; Johnson, M. |
| Abstract Title: | Atezolizumab as 1L therapy for advanced NSCLC in PD-L1 selected patients: Updated ORR, PFS and OS data from the BIRCH study |
| Meeting Title: | IASLC 17th World Conference on Lung Cancer |
| Keywords: | immunotherapy; nsclc; atezolizumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 12 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2016 Dec 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | S251 |
| End Page: | S252 |
| Language: | English |
| ACCESSION: | WOS:000413055800227 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2016.11.239 |
| Notes: | Meeting Abstract: OA03.02 -- Source: Wos |
